SCHEMBL29501484

SCHEMBL29501484

Cc1ccc(Nc2cc(N3CCC(N4CCc5ccccc5C4)CC3)ncn2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 1/20 0.51
CHRM4 P08173 3/20 0.45
LMNA P02545 1/20 0.45
MAPK10 P53779 1/20 0.45
SMO Q99835 1/20 0.43
HRH4 Q9H3N8 1/20 0.43
GRIN2D O15399 3/20 0.41
GRIN3B O60391 3/20 0.41
GRIN1 Q05586 3/20 0.41
GRIN2A Q12879 3/20 0.41
GRIN2B Q13224 3/20 0.41
GRIN2C Q14957 3/20 0.41
GRIN3A Q8TCU5 3/20 0.41
ADRA1A P35348 5/20 0.41
ABL1 P00519 1/20 0.39
BCR P11274 1/20 0.39
CHRM1 P11229 1/20 0.39
ADRA1D P25100 1/20 0.39
ADRA1B P35368 1/20 0.39
CD274 Q9NZQ7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26248321 1.00 SCN9A (0.51) SCN9ACHRM4LMNAMAPK10SMO
SCHEMBL26248126 0.93 SCN9A (0.53) SCN9ACHRM4SMOHRH4GRIN2D
SCHEMBL26248246 0.91 SCN9A (0.55) SCN9ACHRM4SMOHRH4GRIN2D
SCHEMBL29501346 0.91 SCN9A (0.48) SCN9ACHRM4SMOHRH4ADRA1A
SCHEMBL26248210 0.91 SCN9A (0.48) SCN9ACHRM4SMOHRH4ADRA1A
SCHEMBL29501356 0.91 SCN9A (0.48) SCN9ACHRM4SMOHRH4ADRA1A
SCHEMBL29501402 0.90 CHRM4 (0.50) SCN9ACHRM4ADRA1AABL1BCR
SCHEMBL29501486 0.90 SCN9A (0.48) SCN9ACHRM4SMOHRH4GRIN2D
SCHEMBL26248295 0.90 SCN9A (0.48) SCN9ACHRM4SMOHRH4GRIN2D
SCHEMBL26248430 0.90 CHRM4 (0.50) SCN9ACHRM4ADRA1AABL1BCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022048631-A1 COMPOUND HAVING ANTITUMOR ACTIVITY AND USE THEREOF 上海翊石医药科技有限公司 2022-03-10 WO disclosed